Le Lézard
Classified in: Health
Subject: NPT

Independence Blue Cross Foundation announces 'Someone You Know,' a public awareness campaign that addresses the stigma of opioid misuse


PHILADELPHIA, June 19, 2018 /PRNewswire/ -- The Independence Blue Cross Foundation (Foundation) today announced the launch of "Someone You Know," a multimedia campaign focused on reducing the stigma of opioid misuse and inspiring hope in people seeking help with addiction and recovery.

The campaign will feature a mix of print and outdoor advertising, personal videos, and print stories from people affected by opioid misuse, such as men and women in active recovery, a mother who lost her son to an opioid overdose, and a grandmother raising her granddaughter while her son gets treatment. The campaign, which will be seen throughout the five-county southeastern Pennsylvania region, will also include community events, an informational website for individuals seeking information about treatment, and robust social media engagement. "Someone You Know" will culminate in a national conference, hosted by the Foundation in October, that will showcase all the stories, as well as an expert discussion about opioid prevention, treatment, and recovery.

"Through bold, direct, and highly personal stories, we hope to raise public awareness that substance misuse is not a problem that people should be ashamed to discuss, and to let those who are struggling know that there are people out there going through the exact same thing and turning around their lives," said Lorina Marshall-Blake, president of the Independence Blue Cross Foundation. "With simple and inspiring messages like 'Someone you know is overcoming opioid addiction, you can too,' we hope to help remove the stigma that often prohibits people from seeking help and starting on the path to recovery."

"Too often we hear that stigma around substance use disorder leaves people feeling isolated and can keep them out of treatment. Addiction is a disease and, like any other medical condition, people with a substance use disorder deserve compassion and support as they take steps towards recovery," said Jennifer Smith, secretary of the Pennsylvania Department of Drug and Alcohol Programs. "We must all work to change the conversation around addiction so people seeking treatment and living in recovery feel safe, supported, and empowered. This campaign is an important, much needed step towards breaking this stigma."

In addition to this campaign, the Foundation is collaborating with the Justice Center for Research at Penn State University to share additional stories of addiction and recovery to reduce the shame often associated with opioid misuse.

Approximately 1,600 people in southeastern Pennsylvania died in 2016 from an opioid overdose. In Philadelphia alone, there were more than 1,200 overdose deaths in 2017 and 14,000 people are currently in treatment for opioid dependence.

The Foundation, through its Supporting Treatment and Overdose Prevention (STOP) initiative, is increasing awareness about the opioid epidemic and improving access to opioid abuse prevention and treatment in southeastern PA through a variety of strategies and regional partnerships, such as:

About the Independence Blue Cross Foundation:
The Independence Blue Cross Foundation is a charitable, private foundation, whose mission is leading solutions for a healthier community. The Foundation targets the following areas of impact:

Learn more by visiting our website: www.ibxfoundation.org. Connect with the Independence Blue Cross Foundation on Twitter at @ibxfdn.

Media Contact:
Ruth Stoolman
Independence Blue Cross
[email protected]
215-241-4807 (office)
215-667-9537 (cell)

Independence Blue Cross Foundation

SOURCE Independence Blue Cross Foundation


These press releases may also interest you

at 23:00
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....



News published on and distributed by: